90 days later, those receiving the drug showed marked
cognitive improvement compared to placebo, which was correlated with the level of ketones in the blood.
The researchers found that children who received music lessons had significant
cognitive improvements compared to all other children in the study.
Not exact matches
Those treated with EST showed a marked increase in social -
cognitive behaviors, but it took nearly nine months longer for such benefits to emerge
compared to adults treated with CET, suggesting that the more intensive training offered in that approach may help speed
improvement.
The results, published Jan. 3 in the journal Depression and Anxiety, showed that the group using Project: EVO demonstrated specific
cognitive benefits (such as attention)
compared to the behavioral therapy, and saw similar
improvements in mood and self - reported function.
The original, randomized, open label study, which enrolled 20 outpatient men with cirrhosis and recurrent HE receiving standard - of - care (SOC) treatment, had previously reported that a single FMT enema after antibiotic pretreatment improved
cognitive function at Day 20 and reduced HE episodes and hospitalizations over the following 5 months
compared with SOC.1 The long - term outcomes of this study, which were presented today at The International Liver Congress ™ 2018 in Paris, France, demonstrated sustained and statistically significant reductions in the number of HE episodes and hospitalizations as well as
improvements in
cognitive function over 1 year in the men who received FMT
compared with the control group.
The FMT arm also demonstrated sustained and significant
improvements in
cognitive function at 1 year
compared with both baseline and SOC.
Researchers found participants in the group treated with tDCS showed significantly greater
improvements on sensitive, computer - based measures of complex attention and increases in their response times across trials
compared to the group that did
cognitive training games alone.
One year follow - up revealed that AN1792 antibody responders showed
improvements in
cognitive measures as assessed by the neuropsychological test battery (NTB) and a decrease in brain volume
compared with placebo.
The data from the double - blind clinical trial showed that subjects who took ClariMem ® as directed for 12 weeks displayed a statistically significant
improvement in overall
cognitive ability
compared to subjects who took a placebo (inactive sugar pill).
In subjects with mild - to - moderate Alzheimer's,
compared to placebo, daily consumption of the MCTs for 90 days resulted in significant
improvements in multiple
cognitive assessments, with
improvements being greatest in non-ApoE4s who were compliant with dosing (7).
A study done in patients with Alzheimer's disease showed the
improvement of
cognitive function only 90 minutes after receiving a drink that contained medium chained triglycerides, when
compared to a placebo (8).
Additionally, other areas were affected positively, as
compared to the placebo group, who had taken the essential amino acids for lung disease (COPD), including
improvements in: fat - free mass, serum albumin, increased muscle strength, oxygen saturation, and
cognitive dysfunction.
In conclusion, whether fasting actually causes
improvements in metabolic health,
cognitive performance, and cardiovascular outcomes over the long term; how much fasting is actually beneficial; and where the threshold of hormesis resides (i.e., a balance between long - term benefit from fasting
compared with harm from insufficient caloric intake) remain open questions.
Studies using Anipryl ® for the treatment of CDS have shown that after 30 days, 80 % of dogs showed
improvement in overall
cognitive response
compared to pretreatment evaluation and
improvements in individual clinical signs also were observed.
«There was
improvement in
cognitive performance and brain function in those who had the blueberry powder
compared with those who took the placebo,» Krikorian says.
PANSS negative
Cognitive therapy did not have a significant effect on negative symptoms at any follow - up time: estimated
improvement − 1.02 (95 % CI − 2.35 to 0.30)
compared with the treatment as usual group.
This difference was significant when the number of patients who showed a 50 % or greater
improvement was
compared between those who received
cognitive behaviour therapy and the other two groups combined (χ2 = 3D5.18; df = 3D1; P = 3D0.02).
The greater
improvement in the
cognitive behaviour therapy group was underscored by the 63 % (19/30) of patients in this group who improved in work status as
compared with 20 % (6/30) of those who received only medical care.
Similar proportions of patients were employed (56 % vs 39 %) but the patients in the
cognitive behaviour group worked more hours per week (36 vs 24).26 In another study no treatment effect of
cognitive behaviour therapy as
compared with natural course was found on work rehabilitation although self - rated
improvement was associated with
cognitive behaviour treatment.27